NPPA computed the Retail Price of Levocetirizine Dihydrochloride IP 2.5 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg for M/s East African (I) Overseas (Manufacturer) & M/s SRK Puremed LLP (Marketer)

Nov 23, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 12, 2025, issued the Computation of Retail Price of Levocetirizine Dihydrochloride IP 2.5 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg for M/s East African (I) Overseas (Manufacturer) & M/s SRK Puremed LLP (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from April, 2025

• The Retail Price has been computed for Each Film Coated Tablet Containing Levocetirizine Dihydrochloride IP 2.5 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg for M/s East African (I) Overseas (Manufacturer) & M/s SRK Puremed LLP (Marketer)

• The Total MAT is 2,54,98,40,414

[Notification No. 19(4896)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT